MarketPeel
Insider Trading Intelligence
Pricing
…
MW

Marlan D. Walker

TXMD
GENERAL COUNSEL · THERAPEUTICSMD, INC. · CIK 0001820187
FILING MIX · LIFETIME51%/49%
BUYS
27
SELLS
26
TOTAL VALUE
$80.6K
COMPANIES
1
ACTIVE SINCE
May 2021
HOLDINGS NOW
67,492
AVG SELL PX
$1.79
TRADE KIND
SHOWING 53 / 53
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
9 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Marlan D. Walker, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d9+22.22%+8.62%+0.21%+8.41%+7.59%—
14d9+44.44%+13.94%+1.13%+12.80%+12.49%—
30d9+33.33%+26.69%+3.23%+23.46%+20.07%—
60d9+44.44%+13.89%+8.35%+5.55%+2.20%—
90d9+55.56%+13.08%+11.53%+1.55%-0.30%—
180d9+100.00%-8.18%+15.43%-23.61%-20.16%—
1y9+100.00%+4.52%+24.49%-19.96%-73.34%—
2y9(3 pending)+100.00%-58.81%+40.31%-99.13%-101.00%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TXMD · 67,492 shares · as of Nov 3, 2025
086,667173,334260,000346,6672022202320242025SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
FLOW · 27 buys / 26 sellsCOVERAGE · 19 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
67,492——67,492Nov 3, 2025Nov 5, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
490$1.00$48973,639Apr 14, 2025Apr 15, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,167$0.86$1.0K73,149Apr 10, 2025Apr 10, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,136$0.87$99471,982Apr 9, 2025Apr 10, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
3,467——66,032Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
2,311——68,343Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
770——69,113Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
3,467——0Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,733——70,846Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,733——1,733Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
770——0Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
2,311——0Feb 18, 2025Feb 20, 2025 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
4,550$2.24$10.2K62,565Dec 7, 2023Dec 7, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
14,500$2.31$33.5K67,115Dec 6, 2023Dec 7, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
70,000——81,615Dec 5, 2023Dec 7, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
70,000——0Dec 5, 2023Dec 7, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,010——0Apr 26, 2023May 4, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,734——3,466Apr 26, 2023May 4, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,734——12,307Apr 26, 2023May 4, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
692$3.64$2.5K11,615Apr 26, 2023May 4, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,010——14,041Apr 26, 2023May 4, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
3,030——8,999Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,010——0Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,010——10,009Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,734——13,477Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
3,030——0Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
Chief Executive Officer
1,734——11,743Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,734——3,466Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,734——3,466Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
Chief Executive Officer
1,170$3.65$4.3K12,307Apr 12, 2023Apr 14, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
70,000——70,000Feb 21, 2023Feb 23, 2023 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
1,010——1,010Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
General Counsel
388——7,733Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
388——770Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
1,048$4.95$5.2K6,685Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
General Counsel
1,010——6,189Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
General Counsel
1,156——7,345Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
1,156——2,311Dec 6, 2022Dec 9, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
260,000——260,000Mar 31, 2022Mar 31, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
260,000——260,000Mar 23, 2022Mar 28, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
260,000——260,000Mar 23, 2022Mar 28, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
230,000——0Mar 14, 2022Mar 15, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
General Counsel
230,000——258,908Mar 14, 2022Mar 15, 2022 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
100,000——0Sep 29, 2021Oct 1, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
150,000——0Sep 29, 2021Oct 1, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
57,797——57,797Sep 29, 2021Oct 1, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
25,000——0Sep 29, 2021Oct 1, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
120,000——0Sep 29, 2021Oct 1, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
173,333——173,333Jul 1, 2021Jul 2, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASEGRANT
Stock grant
346,667——346,667Jul 1, 2021Jul 2, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
21,592$1.04$22.5K28,908May 11, 2021May 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
SALE
General Counsel
50,500——101,000May 10, 2021May 12, 2021 ↗View →
TXMD
THERAPEUTICSMD, INC.
PURCHASE
General Counsel
50,500——50,500May 10, 2021May 12, 2021 ↗View →
Other insiders · TXMD
Loading peer insiders…
About this filer
CIK 0001820187
ROLE
General Counsel
PRIMARY
TXMD
COMPANIES
1
ACTIVE SINCE
May 2021
MARKETPEEL · /INSIDER/0001820187DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback